Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Weetabix Cereal Sold to Post in £1.4 Billion Deal

XTALKS VITALS NEWS

Cereal

The cereal was sold by Shanghai-based Bright Food, which acquired a controlling stake in the company in 2012. Photo by freeimages.com/Adam Davis

Share this!

April 20, 2017 | by Sarah Hand, M.Sc.

US cereal brand Post Holdings has purchased the UK’s iconic Weetabix band in a deal worth £1.4 billion. The cereal was sold by Shanghai-based Bright Food, which acquired a controlling stake in the company in 2012.

Post is currently the third-largest cereal company in the US, specializing in other breakfast cereals including Honey Bunches of Oats and Grape-Nuts. Along it the popular breakfast cereal, the Weetabix portfolio includes Alpen muesli, Ready Brek, Barbara’s and Weetos.

Bright Food originally acquired Weetabix in the hopes that its popularity in China would grow over traditional Asian breakfast items. However, sales of Weetabix were insufficient to capture enough of the market share.

While sales of Weetabix remain highest in the UK, the breakfast cereal is exported to over 90 countries around the world. It is also primarily manufactured in the UK, with all of the wheat used in the product supplied by local farmers.



“We have long admired Weetabix as a leader in cereal and believe it will be a fantastic strategic fit within Post,” said Rob Vitale, Post’s President and CEO. “Combining together two category leaders continues our strategy of strengthening our portfolio in stable categories and diversifying into new markets, bringing much-loved brands to significantly more customers globally. We are excited about the growth opportunities that this acquisition brings.”

Weetabix employs around 1,800 people around the world, and CEO of the company Giles Turrell has already said that he doesn’t not expect there to be job cuts as a result of the transaction. “Post has no footprint or manufacturing in the UK,” said Turrell. “As long as we remain successful in the marketplace we will continue to manufacture at our plants here in Northamptonshire.”

Post’s annual revenues total $5 billion per year, with Weetabix bringing in £410 million in 2016. The deal is expected to be completed in the third quarter of 2017.


Keywords:  Food Industry, Food Manufacturing, Food Sales


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
German Merck Launches Spinoff Immuno-Oncology Company

June 22, 2017 - Merck KGaA has announced the launch of iOnctura SA, a new immuno-oncology company built around two assets from the Healthcare R&D portfolio of the pharmaceutical company.

Featured In: Biotech News


Ikea Promotes Food Products by Offering Fill-in-the-Blanks Recipe Sheets

June 21, 2017 - In an effort to promote the company’s food business, Ikea recently launched a set of recipes printed on parchment paper that encourage consumers to “fill-in-the-blanks” with ingredients, fold the paper and cook the bag in the oven.

Featured In: Food News


Nanomaterial Promotes Bone Growth after Spinal Fusion Surgery

June 21, 2017 - Researchers at Northwestern University have developed a bioactive nanomaterial capable of effectively stimulating bone regeneration after spinal fusion surgery.

Featured In: Life Science News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Top 5 Most Impactful Tweets in Drug Development During the Last Week

REGISTER FOR THESE WEBINARS

Serialized? Yes. But are Products Still Being Diverted?


Quantitative Protein Profiling in FFPE to Characterize Toxicities Associated with Immune Checkpoint Inhibitors


Are You Choosing the Right Model? A Guide to Selecting Your Next Immuno-Oncology Model


Imaging-based Subtypes of Pancreatic Cancer


Copyright © 2016-2017 Honeycomb Worldwide Inc.